Swiss National Bank - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$26,447,000
+38.5%
1,139,760
-5.1%
0.03%
+30.4%
Q1 2018$19,093,000
-28.2%
1,200,860
-5.8%
0.02%
-20.7%
Q4 2017$26,589,000
+45.5%
1,274,6600.0%0.03%
+38.1%
Q3 2017$18,271,000
-16.0%
1,274,660
+1.9%
0.02%
-19.2%
Q2 2017$21,748,000
+50.0%
1,251,060
-4.7%
0.03%
+44.4%
Q1 2017$14,500,000
-45.7%
1,312,660
-28.7%
0.02%
-57.1%
Q4 2016$26,689,000
-40.3%
1,842,060
+1.1%
0.04%
-41.7%
Q3 2016$44,730,000
+21.6%
1,822,560
-0.6%
0.07%
+20.0%
Q2 2016$36,796,000
-17.9%
1,833,860
+3.5%
0.06%
-26.8%
Q1 2016$44,834,000
-69.2%
1,771,060
+23.5%
0.08%
-76.7%
Q4 2015$145,370,000
-43.4%
1,434,360
-0.5%
0.35%
-46.6%
Q3 2015$256,684,000
-9.8%
1,442,260
+12.9%
0.66%
-10.7%
Q2 2015$284,548,000
+19.4%
1,276,960
+5.4%
0.74%
+16.0%
Q1 2015$238,286,000
+68.7%
1,211,860
+23.0%
0.64%
+20.2%
Q4 2014$141,268,000
+13.1%
984,960
+3.5%
0.53%
+10.4%
Q3 2014$124,867,000
-0.7%
951,460
-4.4%
0.48%
+3.0%
Q2 2014$125,749,000
-6.4%
995,160
-2.2%
0.46%
-11.8%
Q1 2014$134,350,000
+12.0%
1,018,060
-0.4%
0.53%
+12.6%
Q4 2013$119,924,000
+13.7%
1,022,460
+1.2%
0.47%
+6.6%
Q3 2013$105,454,000
+26.6%
1,009,960
+4.7%
0.44%
+19.9%
Q2 2013$83,276,000965,0000.37%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders